XOMA Royalty Management

Management criteria checks 1/4

XOMA Royalty's CEO is Owen Hughes, appointed in Jan 2023, has a tenure of 1.83 years. total yearly compensation is $2.48M, comprised of 5% salary and 95% bonuses, including company stock and options. directly owns 0.3% of the company’s shares, worth $1.08M. The average tenure of the management team and the board of directors is 1.8 years and 5.8 years respectively.

Key information

Owen Hughes

Chief executive officer

US$2.5m

Total compensation

CEO salary percentage	5.0%
CEO tenure	1.8yrs
CEO ownership	0.3%
Management average tenure	1.8yrs
Board average tenure	5.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Owen Hughes's remuneration changed compared to XOMA Royalty's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	-US$35m
Jun 30 2024	n/a	n/a	-US$24m
Mar 31 2024	n/a	n/a	-US$42m
Dec 31 2023	US$2m	US$125k	-US$46m

Compensation vs Market: Owen's total compensation ($USD2.48M) is above average for companies of similar size in the UK market ($USD989.04K).

Compensation vs Earnings: Insufficient data to compare Owen's compensation with company performance.

CEO

Owen Hughes (49 yo)

1.8yrs

Tenure

US$2,482,735

Compensation

Mr. Owen P. Hughes, Jr. serves as Chief Executive Officer of XOMA Royalty Corporation (formerly known as XOMA Corporation) from January 2024 and serves as its Director since January 01, 2023 and served as...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% $ 1.1m
Thomas Burns	Senior VP of Finance & CFO	9.6yrs	US$2.27m	0.12% $ 451.3k
Brad Sitko	Chief Investment Officer	1.8yrs	US$8.56m	0.060% $ 220.2k

1.8yrs

Average Tenure

49yo

Average Age

Experienced Management: 0M26's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% $ 1.1m
Jack Wyszomierski	Independent Chairman	14.3yrs	US$232.53k	0.055% $ 200.4k
Joseph Limber	Independent Director	11.9yrs	US$210.04k	0.053% $ 192.6k
Matthew Perry	Independent Director	7.8yrs	US$197.54k	0.10% $ 365.9k
Barbara Kosacz	Independent Director	5.8yrs	US$196.04k	0% $ 0
Heather Franklin	Independent Director	3.3yrs	US$203.95k	0% $ 0
Natasha Hernday	Independent Director	4.3yrs	US$207.64k	0% $ 0

5.8yrs

Average Tenure

58yo

Average Age

Experienced Board: 0M26's board of directors are considered experienced (5.8 years average tenure).

XOMA Royalty Management

Management criteria checks 1/4

Key information

Recent management updates

Insufficient new directors

XOMA Corporation, Annual General Meeting, May 15, 2024

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

XOMA Corporation, Annual General Meeting, May 18, 2022

CEO & Director recently sold US$303k worth of stock

Recent updates

New minor risk - Shareholder dilution

Third quarter 2024 earnings released: US$1.47 loss per share (vs US$0.60 loss in 3Q 2023)

Insufficient new directors

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$1.37 (vs US$0.59 loss in 2Q 2023)

First quarter 2024 earnings released: US$0.86 loss per share (vs US$0.98 loss in 1Q 2023)

XOMA Corporation (NasdaqGM:XOMA) completed the acquisition of Kinnate Biopharma Inc. (NasdaqGS:KNTE).

XOMA Corporation, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: US$3.56 loss per share (vs US$1.98 loss in FY 2022)

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation (NasdaqGM:XOMA) announces an Equity Buyback for $50 million worth of its shares.

New minor risk - Profitability

Third quarter 2023 earnings released: US$0.60 loss per share (vs US$0.48 loss in 3Q 2022)

New major risk - Revenue and earnings growth

First quarter 2023 earnings released: US$0.98 loss per share (vs US$0.32 loss in 1Q 2022)

Full year 2022 earnings released: US$1.50 loss per share (vs US$0.69 profit in FY 2021)

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

Investor sentiment improved over the past week

Third quarter 2022 earnings released: US$0.48 loss per share (vs US$0.51 loss in 3Q 2021)

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: US$0.53 loss per share (vs US$0.31 loss in 2Q 2021)

Investor sentiment improved over the past week

XOMA Corporation(NasdaqGM:XOMA) dropped from Russell 2000 Dynamic Index

First quarter 2022 earnings released: US$0.32 loss per share (vs US$0.70 loss in 1Q 2021)

Investor sentiment deteriorated over the past week

XOMA Corporation, Annual General Meeting, May 18, 2022

Investor sentiment improved over the past week

Third quarter 2021 earnings released: US$0.51 loss per share (vs US$0.098 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.33 loss in 2Q 2020)

CEO & Director recently sold US$303k worth of stock

First quarter 2021 earnings released: US$0.70 loss per share (vs US$0.49 loss in 1Q 2020)

Full year 2020 earnings released: EPS US$0.82 (vs US$0.23 loss in FY 2019)

Revenue beats expectations

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age